GARP:BATS-iShares MSCI USA Quality GARP ETF (USD)

ETF | Others |

Last Closing

USD 53.51

Change

-0.22 (-0.41)%

Market Cap

USD 0.35B

Volume

0.06M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
FBTC Fidelity Wise Origin Bitcoin T..

-2.33 (-2.75%)

USD 16.57B
INDA iShares MSCI India ETF

+0.41 (+0.76%)

USD 8.92B
PAVE Global X U.S. Infrastructure D..

-0.08 (-0.20%)

USD 7.74B
BUFR First Trust Cboe Vest Fund of ..

-0.12 (-0.40%)

USD 6.29B
BOXX Alpha Architect 1-3 Month Box ..

+0.03 (+0.03%)

USD 5.75B
BBUS JPMorgan BetaBuilders U.S. Equ..

-0.57 (-0.56%)

USD 4.22B
ARKB ARK 21Shares Bitcoin ETF

-2.68 (-2.77%)

USD 4.01B
KNG FT Cboe Vest S&P 500® Dividen..

-0.25 (-0.51%)

USD 3.55B
GSUS Goldman Sachs MarketBeta US Eq..

-0.56 (-0.72%)

USD 2.41B
IFRA iShares U.S. Infrastructure ET..

-0.29 (-0.62%)

USD 2.23B

ETFs Containing GARP

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.87% 15% F 15% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.87% 15% F 15% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.35B 87% B+ 80% B-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike